Screener
Adial Pharmaceuticals ADIL Q2 2026 earnings
Reported August 12, 2026 · Before market open
EPS-$11.25Miss by $10.22
EPS estimate-$1.03
Next report
Nov 18, 2026 (in 2 months)EPS estimate-$0.18
Versus estimates
Diluted EPS
FAQ
- When did Adial Pharmaceuticals report Q2 2026 earnings?
- Adial Pharmaceuticals (ADIL) reported Q2 2026 earnings on August 12, 2026 before market open.
- What were Adial Pharmaceuticals's Q2 2026 revenue and EPS?
- Adial Pharmaceuticals reported eps of $-11.25 for Q2 2026.
- Did Adial Pharmaceuticals beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-1.03 by $10.22.
- How did Adial Pharmaceuticals's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 6150.0% from $-0.18.
- Where can I find Adial Pharmaceuticals's Q2 2026 SEC filings?
- You can read the 8-K/A earnings release (0001213900-26-087439) and the 10-Q periodic report (0001213900-26-090051) directly on SEC EDGAR. The filing index links above go to sec.gov.
